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Summary
Whilst previously rare, some surveys indicate substantial increases in the population
with body mass index (BMI) ≥40 kg/m2 since the 1980s. Clinicians report emerging
care challenges for this population, often with high resource demands. Accurate
prevalence data, gathered using reliable methods, are needed to inform health care
practice, planning, and research. We searched digitally for English language sources
with measured prevalence data on adult BMI ≥40 collected since 2010. The search
strategy included sources identified from recent work by NCD-RisC (2017), grey
sources, a literature search to find current sources, and digital snowball searching.
Eighteen countries, across five continents, reported BMI ≥40 prevalence data in
surveys since 2010: 12% of eligible national surveys examined. Prevalence of BMI
≥40 ranged from 1.3% (Spain) to 7.7% (USA) for all adults, 0.7% (Serbia) to 5.6%
(USA) for men, and 1.8% (Poland) to 9.7% (USA) for women. Limited trend data
covering recent decades support significant growth of BMI ≥40 population. Method-
ological limitations include small samples and data collection methods likely to
exclude people with very high BMIs. BMI ≥40 data are not routinely reported in inter-
national surveys. Lack of data impairs surveillance of population trends, understand-
ing of causation, and societal provision for individuals living with higher weights.
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1 | INTRODUCTION
Prior to the 1970s, body mass index (BMI, kg/m2) ≥40 was rare.1 It
was regarded as a pathological condition, deemed to indicate genetic,
endocrine, or other vulnerability, affecting a tiny, fixed population,
with numbers too small for confident analysis.2 Whilst prevalence can
be minimal in low- to middle-income countries, contemporary studies
suggest rising prevalence, with a current estimated global prevalence
of 0.64% in men and 1.6% in women.3 It is predicted that by 2025,
the global numbers of underweight women will be surpassed by those
with BMI ≥35.3
Although numbers may appear relatively small, compared with
BMI ≥30, frontline health professionals report increasing challenges in
providing safe and effective overall health care for people with very
high BMIs.4 Emerging issues relate to providing for basic care needs
such as appropriate positioning and handling,5,6 continence and
skincare,7 but also cover medical problems such as appropriate dosage
of medicines,8 difficulty in performing medical imaging9 and complex
psychological issues, including stigma, which impact treatment
adherence.10 Evidence from several countries indicates that profes-
sional guidance or training about severe obesity for care givers is
minimal,11-15 threatening quality of care for this population,16 largely
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due to lack of awareness and limited evidence base. This problem is
compounded by stigmatization over size and weight by the media,
within society and among health professionals.17
Furthermore, conventional behavioural weight management
interventions have minimal impact for BMI ≥40.18 Only a minority of
individuals access bariatric surgery,19 and effective nonsurgical inter-
ventions are not yet widely available.20 Thus, once individuals reach a
very high BMI, the potential for sustained weight loss to improve
quality of life and reduce secondary medical complications is limited.
The severity and impact of muscular-skeletal complications reduce
physical activity and mobility, increasing dependence on others and
putting weight loss further out of reach. Consequently, individuals
with BMI ≥40 face reduced life expectancy,21 multimorbidity,22
disability,23 and reduced quality of life.24 In turn, this disease burden
produces multifaceted demands on health and social care services,
raising direct and indirect costs.25 Until recently, evidence on direct
costs of BMI ≥40 have been limited.25 Total health care costs in the
United Kingdom rise linearly, and double, as BMI increases26 from
20 to 40. A recent systematic review of international health care costs
and BMI found costs for people with BMI ≥40 to be 50% greater than
for people with BMI 18.5 to 24.9.27 Costing studies typically exclude
underresearched wider care costs, such as social care28 and nursing
home usage related to functional disability and often long-term
provision,28,29 so current estimates are likely to underestimate the full
costs. Forecasts indicate that increased resource usage will continue,
including costs required to structurally adapt care facilities to the
needs of people with BMI ≥40, alongside providing suitable equip-
ment and training for staff, that is currently missing.30
The present scoping review explores the extent of international
prevalence data on BMI ≥40. It focusses on measured data, given the
potential for error and bias with self-reported anthropometry by indi-
viduals who are overweight.31,32 We assessed the extent and quality
of epidemiological reporting for the BMI ≥40 category internationally,
with a view to improving the documentation of this emerging high-
demand population in future national surveys, to enable development
of a reliable evidence base to guide effective care.
2 | METHODS
The primary epidemiological reports being investigated are health
surveys, undertaken by governments for population surveillance to
inform strategic policy priorities. Health surveys are not usually
reported in the academic literature, unless for a secondary analysis
focussed on a specific issue or subpopulation, often with considerable
time lag. Thus, database search terms for the primary survey would
need to be very broad, making identification through academic
databases highly resource intensive, with results prone to being
incomplete and outdated. For the present scoping review, an alterna-
tive search strategy was therefore applied, based on the sources
identified by the most recent systematic review of international BMI
survey data, with additional searches to update and supplement these
sources, outlined below.
Four key approaches were used to identify potential data sources:
1. Building on previous work
The NCD Risk Factor Collaboration (NCD-RisC) 2017 study on
global BMI trends was chosen as a basis for the initial search, on the
basis of its size and rigour: It used 2416 sources of measured data,
collected up to 2016.33 These sources were compiled from a system-
atic medical database search, supplemented by a worldwide network
of researchers identifying and accessing national measurement sur-
veys via interested parties, including World Health Organization
(WHO). Full details are given in the published paper and its appen-
dix.33 All 2416 sources in the NCD-RisC appendix were screened as
per the inclusion criteria in Table 1, with digital snowball searching
used to locate individual data sources.
2. Digital searching of current grey literature sites
Searching of key international organizations websites known to
compile BMI population survey data was undertaken, focussing on
the Organization for Economic Cooperation Development (OECD),
the WHO, and the World Obesity Federation (WOF).
3. Systematic database search
To ensure identification of any new sources since 2016 in the
academic literature, a modified version of the NCD-RisC literature
search was undertaken in Medline and Embase using the search terms
TABLE 1 Source inclusion and exclusion criteria
Included Excluded
Reports BMI ≥40 prevalence Does not report
BMI ≥40 prevalence
Measured anthropometric data Self-reported
anthropometric data
Nationally representative data:
sampling strategy showing
national coverage based on
electoral roll/census or similar,
with at least stratification for
age and sex
Nonnationally representative,
subpopulations by
age/sex/rural/urban/
regional/community
Adults aged 15 years or older Children and adolescents
Data collected in or since 2010 Data collected pre-2010
Data already compiled in a publicly
available report/websitea
Data requiring
registration/searching
through raw datab
Report in English language Report not in English language
Not already identified by search Already identified through
alternative source
Abbreviation: BMI, body mass index.
aFor immediate use by decision makers.
bMay be available to academics, but requiring analysis and presentation
prior to use by decision makers.
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in Appendix A. Results from conference proceedings were deliberately
included, as they can provide the first exposure of research analysis,
highlighting new or updated data sources, whilst full articles com-
monly take much longer to publication, if indeed they are ever publi-
shed in full. Sources were searched both for BMI ≥40 data, but also to
identify any new sources/health surveys not already located through
parts 1 and 2 of the search process.
4. Digital snowball searching
Whilst NCD-RisC identified sources, individual sources needed
located and accessed, often directly from a website of government
agencies or international bodies. This was undertaken digitally, seek-
ing previously unknown sources or articles.
All sources were screened using inclusion criteria in Table 1.
Figures 1A and 1B represent the search process, with numbers of
studies included and excluded at each stage. Searches took place
between June and September 2019. Where successive or annual-
ized surveys were identified, sources were checked for the most
current data, with the most recent data retained. If multiple studies
for the same country or source were identified, the one with the
largest sample, or that provided the most information to data
extraction, was retained. These pragmatic methods adopt a
systematic approach to exploring the broad evidence landscape in
an emerging area, highlighting gaps for future, more detailed
research.34
3 | RESULTS
Prevalence data of measured BMI ≥40 from 2010 onwards were
located for 18 individual countries, on all five continents, comprising
12% of eligible national survey data examined (Table 2) either in its
primary form (n = 10) or through secondary analysis (n = 8). Data were
very recent, with half of the countries reporting prevalence from
2015 onwards, and only three back to 2010. None of the original
sources located reported BMI data categories higher than BMI ≥40
(for example, BMI ≥45/≥50), with just one secondary analysis from
Spain doing so.41
Germany,37 Saudi Arabia,43 Seychelles,46 and Poland38 report
only for men and women separately, with no data for combined-sex
adults. In contrast, only combined-sex-adult data were available for
Brazil48 and Portugal.39 All regions of the world (as defined by WHO)
contained a country with rates above 4% for women, and 2% for men,
with the exception of Africa, where the maximum was Seychelles with
1.5% for men.46 Other than Brunei Darussalam,51 rates for women
were universally higher than for men.
Prevalence rates are presented graphically in Figure 2A-C. The
United States has the highest prevalence,49 with rates across all
adults, men, and women ranging between 5.6% and 9.7%. Other
countries with higher rates (5.0%-7.7%) for all adults and women are
New Zealand,45 Kuwait,42 and Barbados,47 although rates in men are
markedly lower. Australia,44 Canada,50 Scotland,36 England,35 and
Saudi Arabia all have rates in the region of 2.5% to 5.5% for all adults
and/or women, again with men notably lower. Germany, Serbia,40
Spain, Portugal, Poland, Brazil, and Malaysia52 display the lowest rates
between 0.7% and 2.8%. Brunei Darussalam and Seychelles both
exhibit disparate prevalence patterns from those above for men and
women.
Table 2 is modelled on Foresight's International Evidence
Review,53 which when published illustrated the general availability
of regionally comparative BMI ≥30 prevalence data. The rigorous
inclusion criteria applied during searching means that most sources
(with potential exception of Spain and Poland) were from surveys
done or supported by national government agencies, with primary
reporting through grey literature sources. Due to the constraints
associated with gathering measured data, total sample sizes tend
to be relatively small, with 13 countries being <8000, and five
above this. With prevalence under 10% of these numbers, wide
confidence intervals result for BMI ≥40, as seen in Table 2.
Less than half of the countries included have regular surveil-
lance, ranging from annual to three to four yearly (Table 2:
England, Scotland, Canada, New Zealand, Australia, and the United
States), significantly limiting analysis of trends over time. Reporting
from other countries appears to be more ad hoc and unpredictable,
without planning for regular surveillance.
3.1 | International survey data sources
Globally, BMI ≥40 data were generally poorly available compared
with BMI ≥30 data. Seventy-one NCD-RisC sources had BMI ≥25/
≥30 data available in English, of which only 11 (15%) provided
BMI ≥40 data. Forty six studies out of the 80 screened for the lit-
erature search reported mean BMI or BMI ≥25/≥30 data, with just
one (2%) reporting BMI ≥40. For Africa, only the island state of
Seychelles presented BMI ≥40 data.
The OECD annually publishes country by country Health Sta-
tistics with measured data sources for 26 out of 44 countries in
its 2019 report.54 Many major European countries are missing, as
the European Health Interview Survey (EHIS), which is the primary
health data collection tool for Eurostat, the Statistics office of the
European Union, uses self-reported height and weight data.55 The
European Health Examination Survey does include measured data
but appears not to have been widely adopted.56
Additional grey sources were searched, including WHO website,
where the categorizations consistently applied to data were BMI 25.0
to 29.9 and ≥30, with no additional categorization for BMI ≥40. The
WOF website supports the Global Obesity Observatory, featuring a
searchable interactive map detailing national overweight and obesity
rates, with data sources referenced. All 179 available countries were
individually searched, with 12 displaying data on BMI ≥40,57 of which
four had not been previously identified and fitted the inclusion
criteria.
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3.2 | Data quality
To enable assessment of data quality, the column headers of Table 2
highlight basic quality parameters appropriate to national health
surveillance,58 with additional categories particularly relevant to the
population with BMI ≥40.
Survey methods for the six countries with regular surveillance in
place (England, Scotland, Australia, New Zealand, Canada, and the
United States) are available for scrutiny on public websites. These sur-
veys employ complex sample design, aimed at reducing bias and with
weighting to reflect the age/sex stratification of the population.
Response rates are difficult to compare, due to heterogeneity of defi-
nitions. As ongoing programmes, the surveys measure nonresponse
across years, which appears to be a growing challenge, with Australian
data showing the nonresponse rate for the BMI module specifically,
increasing from 26.8% in 2014 to 2015 to 33.8% in 2017 to 2018.59
F IGURE 1 Search strategy (A) part 1 and 2: NCD-RisC sources and grey sources, (B) part 3 & 4: literature search
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Secondary analyses tended to have less available detail on sampling
and methodology, with those for Spain41 and Brazil48 referencing pre-
vious publications not available in English.
Data collection methods of included surveys were scrutinized for
factors that may affect participation of people with BMI ≥40
(Table 2). Eleven countries specifically stated exclusion criteria, which
were very similar, namely, the institutionalized population.
This excluded those in hospitals and, apart from New Zealand, people
in care homes. No surveys appeared to document an upper BMI limit,
but the capacity of scales used has potential to enact this, effectively
meaning individuals with weights over the maximum capacity of the
instrument are either excluded or estimated self-reports.35 No clearT
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F IGURE 2 International body mass index (BMI) ≥40 prevalence
rates by country: (A) all adults, (B) men, and (C) women
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data on scale capacity could be found for seven countries, two coun-
tries appear to have used scales with a maximum capacity of 150 kg,
whilst nine had scale capacities of 200 kg or over. Functional mobility
limitations may affect participants' ability to stand on scales or attend
examination centres outside the home. For two countries, place of
anthropometry data collection was unavailable, nine countries used
home visits, whilst seven required participants to leave their home,
although some of these offered transport if needed.
4 | DISCUSSION
Whilst good quality BMI ≥30 prevalence data are now available
globally, largely due to the widespread implementation of surveil-
lance tools such as STEPS, there are few robust measured data on
BMI ≥40 or higher categories. The published surveys generally use
similar proven methodologies to obtain population-representative
data. However, the methods used to assess BMI ≥30, risk provid-
ing inaccurate results for higher BMI categories, for example, if
they require mobility of participants or if the scales used have an
upper limit of 200 kg. Hence, true prevalence may be higher than
stated in Table 2.
The data that are available have limitations, notably wide con-
fidence intervals for higher BMI categories, making it difficult to
determine the significance of annual changes. If, as predicted, num-
bers with BMI ≥40 continue to grow, this problem may diminish,
although is unlikely to disappear altogether as the cost of gathering
measured data limits sample sizes. The limited long-term trend data
available help to overcome uncertainties with large confidence
intervals for the smaller numbers with BMI ≥40. Since 1995, BMI
≥40 prevalence in Scotland has trebled for women aged 16 to
64 years.60 Australia saw similar increases of 2.9-fold for men and
2.0-fold for women between 1995 and 2011 to 2012.61 Preva-
lence of BMI ≥40 in the United States quadrupled between 1976
and 2004, substantially surpassing the rise in BMI ≥30.62 Preva-
lence in men in England aged 16 years or older experienced an
eight-fold increase since 1995,35 but Brazil reported the most dra-
matic increase of nearly 20-fold between 1974-1975 and 2013.48
Overall population distributions have thus consistently shifted
upwards, as illustrated in Figure 3, comparing waves of US
NHANES data from 1967-1980 to 2005-2006.63
Comparison with analyses of self-report surveys from the United
States and Canada, which allow for much larger samples, all show dis-
proportionately larger growth in higher BMI categories, with increases
of up to 10-fold in the BMI ≥40 category.64-66 This is despite sugges-
tions that the underestimation of weight for self-report data is likely
to be greater with higher BMI.31 Thus, despite wide confidence inter-
vals in individual survey years and some variations in methodologies,
measured trend data evidence from several countries, together with
larger-scale self-report datasets, all support a long-term rise in BMI
≥40.
Two key sources of data for NCD-RisC and WOF were STEPS
reports and Demographic Health Survey (DHS) country reports.
The STEPwise approach, featuring three different level of “steps”
of key risk factor assessments for NCDs, was developed by WHO,
to aid countries increase their surveillance capacity.67 One hundred
and thirteen country reports or data sheets were publicly available
on the WHO STEPS site at the time of searching.68 DHS is
supported by the US Agency for International Development
(USAID), to inform planning particularly in relation to maternal and
child health, with over 93 standard DHS reports since 2010 on its
website.69 Both of these are easily accessible population surveil-
lance tools, widely used by low- to middle-income countries, with
standard methodologies including collecting measured height and
weight in a household setting. Current standard reporting practice
for STEPS and DHS focusses on BMI 25.0 to 29.9 and ≥30, with
no additional categorization for BMI ≥40.
International health surveillance provides reliable health infor-
mation that is comparable over time and between populations. It
has allowed documentation of a nutrition transition that is rooted
in the impact of large-scale social changes such as reduction in
physical activity, increased urbanization, and greater consumption
of processed food.70 Whilst regional variation remains, the major
global concern has moved away from underweight as the primary
nutrition issue, towards excess weight as the leading cause of mor-
bidity and mortality through secondary noncommunicable dis-
eases.23 This has already occurred to such a degree that BMI ≥35
in women now surpasses underweight in 165 countries for women
and 113 for men.3 Yet current national documentation of BMI dis-
tribution does not reflect this shift, with the focus still on reporting
categories <18.5 to ≥30, and/or mean BMI, as the DHS and STEPS
reports evidence. This historical bias is obscuring the significant
F IGURE 3 Changes in the distribution of body mass index (BMI)
between 1976-1980 and 2005-2006, adults aged 20 to 74 years:
United States.63 Data are age adjusted by the direct method to the
year US Census 2000 estimates using age groups 20 to 39, 40 to
59, and 60 to 74. Overweight is BMI of 25.0 to 29.9 kg/m2; obesity is
BMI at or above 30.0 kg/m2; and severe obesity is BMI at or above
40.0 kg/m2. Pregnant women are excluded from the analysis. Sources:
NCHS, National Health Examination Survey, and National Health and
Nutrition Examination Surveys
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changes in higher BMI categories.42,66 Without characterizing this
progression, policymakers and planners are unable to respond
effectively to the needs of the population or evaluate the effec-
tiveness of policies.
The example of Kuwait in this review provides a case in point.
The original 2014 STEPS report on the WHO website documents
the mean BMI and four separate BMI categories <18.5, 18.5 to
24.9, 25.0 to 29.9, and ≥30, without ≥40, as a distinct category.68
The BMI ≥40 data were later reported by the analysis of
Weiderpass et al of the original STEPS dataset, illustrating that the
data had been collected but gone unreported.42 Table 2 shows
Kuwait's prevalence rates as second highest only to the United
States, providing valuable information regarding BMI population
distribution, in a region where no other sources of all adult preva-
lence were found.
One practical solution would be for WHO and similar agencies
to call for data on the BMI ≥40 population to be included when
reporting all anthropometry surveys. The National Child Measure-
ment Programme in England took an equivalent step in 2018,
adding severe obesity as a reporting category.71 Given that the
prevalence of BMI ≥50 is now similar to that of the BMI ≥40 cate-
gory about 20 years ago, with some real-world datasets including
categories of 50/60/70,72 it may be wise also to include reporting
BMI ≥50, to map future trends. This would hugely increase the
amount of BMI ≥40 data available globally, with little extra cost,
given that the data are already collected. For countries with small
numbers to report, the need for caution in interpretation would be
dealt with in the same way for low numbers in any category, for
example, underweight.
4.1 | Causation
The lack of data on BMI ≥40 trajectories by region, nation, age, sex,
and class makes it difficult to explore causation. Improved interna-
tional data, ideally from longitudinal studies, would promote compari-
son between countries, taking into account their differing social and
economic contexts.73 Together with the emergence of large-scale
genome studies looking at the inherited susceptibility to BMI ≥40,74
reasons for the escalation of high body weight may be more accu-
rately sought. There are some indications of associations with lower
socio-economic status in some populations,75,76 but these patterns
require further study. Concerningly, some countries report increasing
rates of the highest BMI groups growing for children and
adolescents,71,77 with potential for excess weight to track through
into adulthood. This would differ from current patterns, when rates
are lower in early adulthood, peaking in middle age.35,49,78 Unusually,
the survey data from Brunei Darussalam showed 19- to 29-year-olds
having some of the highest rates of BMI ≥40 across the age
trajectory.51
A lack of prevalence data keeps the population hidden,
preventing development of appropriate weight management ser-
vices to treat this population group, along with comparative
analysis of different treatment models and health care systems.25
BMI ≥35 with comorbidities or BMI ≥40 with or without com-
orbidities is a commonly applied threshold for bariatric surgery, yet
access to surgery is often very limited.19,79 Evidence on effective
alternatives to surgery or prevention is needed, whilst access to
traditional services can be difficult for people with BMI ≥40 due to
functional disability.80 Improved global prevalence data would facili-
tate work on economic costing of treatment and prevention for
the population with BMI ≥40.
4.2 | Consequences of rise in prevalence
Whilst numbers may appear small in terms of proportion of the whole
population, given that these are at national scale, they translate into
significant absolute numbers with a large real-life impact on care
provision.
4.2.1 | Health risk and comorbidities
It is well recognized that BMI can be a poor proxy for body fat,
and in many studies, waist circumference or evidence-based predic-
tive equations for total body fat are better than BMI for assessing
health risk, particularly cardiac and metabolic health outcomes.81-84
Consequently, surveys from the United States, England, Scotland,
New Zealand, and Australia all measure waist circumference. How-
ever, people with BMI ≥35 exceed these cut points, often with a
large abdominal fat apron, making methods which incorporate waist
circumference unlikely to be reliable for very high body weights.
Thus, BMI remains the best available simple estimate of body fat
at the highest levels. Surveys and studies need to consider data
collection methods, particularly scales capable of weighing at least
200 kg, with easily accessible wide and low platforms, ideally offer-
ing home visits to facilitate accurate data collection from people
with high BMIs. Additionally, a review is needed regarding the
treatment of what have historically been seen as biologically
implausible values (BIVs), the majority of which have been found
to be accurate.85 The definition of BIVs and use of upper thresh-
olds for weight and BMI in research studies requires reexamination
in view of the documented shift in population distribution towards
heavier BMIs.
Elevated health risk translates into increased prevalence of
multimorbidity (co-occurrence of ≥2 conditions) compared with
those of normal weight by nearly two86 to seven times,40 particu-
larly for cardiometabolic multimorbidity.22 Alongside physical dis-
eases, risk of depression increases with BMI,87 together with
functional disability,88 with increasing numbers of people with BMI
≥40 living in care homes.29 As such care of these multiple obesity-
related consequences amplifies health care costs considerably.89
Given the rise in prevalence and size of these costs, in addition to
older costing studies being limited by BMI thresholds that are now
too low, this is likely to become of increasing concern globally.
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4.2.2 | Planning
As an emerging population, people with BMI ≥40, especially those
with BMI ≥50 and ≥60, have needs that are currently often
unaddressed by service providers.4 Increasingly, changes to care envi-
ronments are being needed to accommodate larger body sizes, requir-
ing adjustments such as widened doorways, reinforced floors, suitable
seats, and larger rooms. Problems featured in the health literature
demonstrate the scope of challenges, such as evacuation planning,90
diagnostic scanning,9 and positioning during surgery in theatre.91
Documented requirements include staff training,11 specialist equip-
ment provision,91 and development of specialist clinical protocols cov-
ering essential areas, such as tissue viability guidance.92 However,
issues are not restricted to health care but affect all aspects of life,
including specialist housing,93 adapted workplace design,94 larger
sized fashionable and safety clothing,95 and barriers to travelling.96
Projections of future severe obesity prevalence using different
datasets agree in predicting continued rises for the foreseeable
future.1 Current analyses suggest five million living with a BMI ≥40 in
the United Kingdom by 2035, with rates up to 20% for Welsh women
aged 55 to 64 years97 and over 20 million people affected in the
United States.30 Better characterization of the population with BMI
≥40 is required to support organizational and societal readiness for
this population. Adaptations are expensive in time and money, partic-
ularly when made retrospectively, underlining the need for accurate
planning to happen now.
4.3 | Strengths and limitations
This review has concentrated on robustly measured data to estab-
lish the international prevalence rates for BMI ≥40. Whilst the
rationale for exclusion of self-report data is sound, in that it com-
monly underestimates BMI, the exclusion also acts as a limitation,
for example, by excluding EHIS data, which covers many European
countries. The sample sizes possible with measured data are
reduced by the need for resources to make measurements, and
there is potential bias against including very heavy individuals
whose mobility is impaired. In some cases, the upper limit of scales
excluded the heaviest individuals. These limitations would tend to
underestimate the true prevalence of the highest BMI categories,
not overestimate.
Applying a lower threshold of BMI ≥35 would have broadened
the available data, whilst potentially weakening the focus on the
highest BMI category, where costs and clinical complexity is greatest.
Some studies report the lower threshold of BMI ≥35 particularly those
examining Asian populations where different BMI cut-offs relating to
overweight and obesity are often applied.98
Limiting the review to the English language prevented examina-
tion of some original data sources, which could only be located in
their native language, for example, Spanish for Chile and Mexico. It
was not possible to locate English versions of these, and resources
did not allow for translation. The OECD reports these original sources
in English in its database, but only at BMI thresholds of 25.0 to 29.9
and BMI ≥30, with prevalence for Chile and Mexico the highest in
the world, above even those of the United States.99 Thus, they are
likely to have significant BMI ≥40 prevalence. Additionally, whilst the
search processes were broad, encompassing a variety of sources and
used systematic methods, they were not exhaustive, as might be
expected from a formal systematic literature review or meta-analysis.
We believe that they represent a reliable summary of the current
evidence base on BMI ≥40, as it is available to decision makers. Some
individual sources have not been included, notably those from non-
English publications, but they are unlikely to alter the very consistent
conclusions.
5 | CONCLUSION
This review highlights the poor availability of robust international
data available on the emerging issue of BMI ≥40 prevalence. The
measured data available suggest significant prevalence on all five
continents, with proportionally large rises in recent decades. Given
the multiple care challenges, high resource needs and poor current
evidence base for this population, routinely reporting BMI ≥40 and
higher categories in national surveys, would be valuable, with
appropriate caveats for interpreting the still small numbers in indi-
vidual surveys. Accurate characterization of the subpopulations
with BMI ≥40 and higher categories requires consideration of mea-
surement equipment and the mobility limitations of individuals with
high BMI.
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APPENDIX A
Search strategy and terms, last search undertaken on 28 September
2019.
Medline (Ovid) and Embase
(National health survey or national population surveillance or
national prevalence or epidemiological survey).tw
(BMI or body mass index or obes*).tw
Limited to humans, (all adults (19 plus years)), English language,
2016 – current, All types of publication
(Child or children or adolescents or baby). Tw records remove
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